リサマリー・コリンズ博士は、バイオテクノロジーおよびその他のライフサイエンス企業が、競合他社の脅威に耐え、ビジネス価値を最大化できる強力な特許ポートフォリオの構築を支援しています。
Lisamarie’s counsel extends to all aspects of patent procurement and portfolio management, including noninfringement, freedom-to-operate and validity opinions; due diligence; and licensing. The companies she works with develop innovations related to immunology, molecular and cell biology, cell-based therapeutics, therapeutic compositions, methods of treatment, diagnostics, probiotics, agricultural biotechnology, and plant technology. She is a member of the Chemical, Biotechnology & Pharmaceutical Practice, as well as the Health Care & Life Sciences and Innovative Technology Sectors.
Lisamarie joined Foley as a summer associate and later a law clerk. Previously, she worked as a law clerk with the Wisconsin State Department of Corrections. Prior to her legal career, she conducted research and taught in the areas of physiological and biological sciences at the Medical College of Wisconsin and Marquette University.
受賞歴と表彰
- The Best Lawyers® in America Ones to Watch – Intellectual Property Law (2021-2024); Technology Law (2021-2024)
所属
- Member of the State Bar of Wisconsin Intellectual Property Section
発表と出版物
- Co-author, “LDT Proposals: Concerns about the FDA’s proposal LDT regulations on test providers and patients,” Advanced Healthcare Network for Laboratory (March 14, 2016)
- Co-author, “Laboratory Developed Tests (LDTs) – An emerging area of FDA regulation,” Advance Healthcare Network for Laboratory (December 28, 2015)
- Author, “Dueling Records: Are Statements in Your 510(k) Putting Your Patents at Risk?” BNA Bloomberg 210 (October 30, 2015)
- Author, “Copyrightable Works in the Undergraduate Student Context: An Examination of the Issues,” Marquette Intellectual Property Law Review, 285 (2013)
- Co-author, “Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry,” Physiol Genomics, 40: 208-215 (2010)
- Co-author, “Quantitative comparison of lipoprotein fractions derived from human plasma and serum by liquid chromatography-tandem mass spectrometry,” Proteome Science, 8:42 (2010)